iCAD, Inc. (ICAD) to Highlight Xoft System to Treat Skin, Breast and Gynecological Cancers at ASTRO
9/19/2013 11:08:02 AM
ASTRO Booth Number 2449--iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that its Xoft subsidiary will be showcasing its Xoft® Axxent® Electronic Brachytherapy System® at the American Society for Radiation Oncology’s (ASTRO) 55th Annual Meeting being held from September 22-25, 2013 in Atlanta at booth #2449.
Help employers find you! Check out all the jobs and post your resume.
comments powered by